195 related articles for article (PubMed ID: 21883346)
1. Histological and molecular features of lipomatous and nonlipomatous adipose tissue in familial partial lipodystrophy caused by LMNA mutations.
Araújo-Vilar D; Victoria B; González-Méndez B; Barreiro F; Fernández-Rodríguez B; Cereijo R; Gallego-Escuredo JM; Villarroya F; Pañeda-Menéndez A
Clin Endocrinol (Oxf); 2012 Jun; 76(6):816-24. PubMed ID: 21883346
[TBL] [Abstract][Full Text] [Related]
2. Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy.
Araújo-Vilar D; Lattanzi G; González-Méndez B; Costa-Freitas AT; Prieto D; Columbaro M; Mattioli E; Victoria B; Martínez-Sánchez N; Ramazanova A; Fraga M; Beiras A; Forteza J; Domínguez-Gerpe L; Calvo C; Lado-Abeal J
J Med Genet; 2009 Jan; 46(1):40-8. PubMed ID: 18805829
[TBL] [Abstract][Full Text] [Related]
3. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism.
Friesen M; Cowan CA
Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996
[TBL] [Abstract][Full Text] [Related]
4. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
[TBL] [Abstract][Full Text] [Related]
5. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
[TBL] [Abstract][Full Text] [Related]
6. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients.
Jan V; Cervera P; Maachi M; Baudrimont M; Kim M; Vidal H; Girard PM; Levan P; Rozenbaum W; Lombès A; Capeau J; Bastard JP
Antivir Ther; 2004 Aug; 9(4):555-64. PubMed ID: 15456087
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinedione response in familial lipodystrophy patients with LMNA mutations: a case series.
Luedtke A; Boschmann M; Colpe C; Engeli S; Adams F; Birkenfeld AL; Haufe S; Rahn G; Luft FC; Schmidt HH; Jordan J
Horm Metab Res; 2012 Apr; 44(4):306-11. PubMed ID: 22274718
[TBL] [Abstract][Full Text] [Related]
8. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.
Wojtanik KM; Edgemon K; Viswanadha S; Lindsey B; Haluzik M; Chen W; Poy G; Reitman M; Londos C
J Lipid Res; 2009 Jun; 50(6):1068-79. PubMed ID: 19201734
[TBL] [Abstract][Full Text] [Related]
9. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism.
Vantyghem MC; Faivre-Defrance F; Marcelli-Tourvieille S; Fermon C; Evrard A; Bourdelle-Hego MF; Vigouroux C; Defebvre L; Delemer B; Wemeau JL
Clin Endocrinol (Oxf); 2007 Aug; 67(2):247-9. PubMed ID: 17524034
[TBL] [Abstract][Full Text] [Related]
10. The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks.
Briand N; Guénantin AC; Jeziorowska D; Shah A; Mantecon M; Capel E; Garcia M; Oldenburg A; Paulsen J; Hulot JS; Vigouroux C; Collas P
Hum Mol Genet; 2018 Apr; 27(8):1447-1459. PubMed ID: 29438482
[TBL] [Abstract][Full Text] [Related]
11. Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660).
Lanktree M; Cao H; Rabkin SW; Hanna A; Hegele RA
Clin Genet; 2007 Feb; 71(2):183-6. PubMed ID: 17250669
[No Abstract] [Full Text] [Related]
12. The retinol acid receptor B gene is hypermethylated in patients with familial partial lipodystrophy.
Cortese R; Eckhardt F; Volleth M; Wehnert M; Koelsch U; Wieacker P; Brune T
J Mol Endocrinol; 2007 Jun; 38(6):663-71. PubMed ID: 17556535
[TBL] [Abstract][Full Text] [Related]
13. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.
Caron M; Auclair M; Donadille B; Béréziat V; Guerci B; Laville M; Narbonne H; Bodemer C; Lascols O; Capeau J; Vigouroux C
Cell Death Differ; 2007 Oct; 14(10):1759-67. PubMed ID: 17612587
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of Fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes.
Oldenburg AR; Delbarre E; Thiede B; Vigouroux C; Collas P
Hum Mol Genet; 2014 Mar; 23(5):1151-62. PubMed ID: 24108105
[TBL] [Abstract][Full Text] [Related]
15. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy.
Vantyghem MC; Vincent-Desplanques D; Defrance-Faivre F; Capeau J; Fermon C; Valat AS; Lascols O; Hecart AC; Pigny P; Delemer B; Vigouroux C; Wemeau JL
J Clin Endocrinol Metab; 2008 Jun; 93(6):2223-9. PubMed ID: 18364375
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy.
Guallar JP; Gallego-Escuredo JM; Domingo JC; Alegre M; Fontdevila J; Martínez E; Hammond EL; Domingo P; Giralt M; Villarroya F
AIDS; 2008 Mar; 22(5):575-84. PubMed ID: 18316998
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix remodeling and transforming growth factor-β signaling abnormalities induced by lamin A/C variants that cause lipodystrophy.
Le Dour C; Wu W; Béréziat V; Capeau J; Vigouroux C; Worman HJ
J Lipid Res; 2017 Jan; 58(1):151-163. PubMed ID: 27845687
[TBL] [Abstract][Full Text] [Related]
18. Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2.
Corsa CAS; Walsh CM; Bagchi DP; Foss Freitas MC; Li Z; Hardij J; Granger K; Mori H; Schill RL; Lewis KT; Maung JN; Azaria RD; Rothberg AE; Oral EA; MacDougald OA
Diabetes; 2021 Sep; 70(9):1970-1984. PubMed ID: 34088712
[TBL] [Abstract][Full Text] [Related]
19. Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation.
Davies SJ; Ryan J; O'Connor PBF; Kenny E; Morris D; Baranov PV; O'Connor R; McCarthy TV
Adipocyte; 2017 Oct; 6(4):259-276. PubMed ID: 28872940
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2.
Resende ATP; Martins CS; Bueno AC; Moreira AC; Foss-Freitas MC; de Castro M
Clin Endocrinol (Oxf); 2019 Jul; 91(1):94-103. PubMed ID: 30954027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
